Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11041321rdf:typepubmed:Citationlld:pubmed
pubmed-article:11041321lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0278080lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0599946lld:lifeskim
pubmed-article:11041321lifeskim:mentionsumls-concept:C0049894lld:lifeskim
pubmed-article:11041321pubmed:issue1lld:pubmed
pubmed-article:11041321pubmed:dateCreated2001-2-15lld:pubmed
pubmed-article:11041321pubmed:abstractTextThe dopamine (DA) D3/2 agonist 7-OH-DPAT attenuates the acute antinociceptive, discriminative stimulus, locomotor activating, and reinforcing effects of mu agonists (for example, morphine).lld:pubmed
pubmed-article:11041321pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:languageenglld:pubmed
pubmed-article:11041321pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:citationSubsetIMlld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11041321pubmed:statusMEDLINElld:pubmed
pubmed-article:11041321pubmed:monthSeplld:pubmed
pubmed-article:11041321pubmed:issn0033-3158lld:pubmed
pubmed-article:11041321pubmed:authorpubmed-author:CookC DCDlld:pubmed
pubmed-article:11041321pubmed:authorpubmed-author:PickerM JMJlld:pubmed
pubmed-article:11041321pubmed:authorpubmed-author:BarretoA BABlld:pubmed
pubmed-article:11041321pubmed:authorpubmed-author:SyvanthongCClld:pubmed
pubmed-article:11041321pubmed:issnTypePrintlld:pubmed
pubmed-article:11041321pubmed:volume152lld:pubmed
pubmed-article:11041321pubmed:ownerNLMlld:pubmed
pubmed-article:11041321pubmed:authorsCompleteYlld:pubmed
pubmed-article:11041321pubmed:pagination93-104lld:pubmed
pubmed-article:11041321pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:meshHeadingpubmed-meshheading:11041321...lld:pubmed
pubmed-article:11041321pubmed:year2000lld:pubmed
pubmed-article:11041321pubmed:articleTitleThe dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.lld:pubmed
pubmed-article:11041321pubmed:affiliationDepartment of Psychology, University of North Carolina at Chapel Hill, 27599-3270, USA.lld:pubmed
pubmed-article:11041321pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11041321pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed